PharmOutcomes’ owner to be sold to Optum UK under £1.24bn deal

Health services company Optum UK has agreed to buy healthcare software and systems provider EMIS Group, which owns the PharmOutcomes platform, in a deal worth over £1 billion.

PharmOutcomes
9,122 pharmacies selected PharmOutcomes to provide the Community Pharmacist Consultation Service

Bordeaux UK Holdings II Limited – an affiliate of Optum UK and part of US healthcare and insurance company UnitedHealth Group – agreed to buy EMIS Group for a cool £1.24 billion, the companies revealed last week (June 17).

Free to registered users

Register to gain full access to C+D and C+D Community content

Sign in or register for free

Latest from News

Retired pharmacist crushed to death in canal boat accident

 
• By 
 • comment0

Margaret Billings sustained fatal injuries when she was caught between a moving boat and a riverbank during a day out “with family and friends”, an inquest has found.

NHSE scrapped: ‘Fresh start or just more political chaos?’

 
• By 
 • comment3

C+D rounds up some of the immediate pharmacy reaction to news that NHS England will be abolished, with more control moving back to the government and local leaders…

New primary care medical director role as 2-year NHSE axing begins

 
• By 
 • comment3

Wes Streeting has revealed that the DH is “immediately” working to scrap NHS England (NHSE) and put a new “transformation team” in place – adding that it is in the “very final stages” of concluding a new pharmacy contract deal.

More from Business

breaking news

IN FULL: Boots’ parent company sold in $24bn private equity deal

 
• By 
 • comment

Walgreens Boots Alliance (WBA) has “entered into a definitive agreement to be acquired” by private equity firm Sycamore Partners.

Jhoots accounts: Shareholder funds tumble while debts soar

 
• By 
 • comment

Jhoots Chemist’s accounts for 2024 have revealed an almost £2 million year-on-year dip in shareholder funds – as debts to creditors increase more than £2m.